Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Average (2020 - 2025)

Celularity has reported Equity Average over the past 6 years, most recently at -$22.8 million for Q3 2025.

  • Quarterly results put Equity Average at -$22.8 million for Q3 2025, down 201.11% from a year ago — trailing twelve months through Sep 2025 was -$22.8 million (down 201.11% YoY), and the annual figure for FY2024 was $24.9 million, down 79.24%.
  • Equity Average for Q3 2025 was -$22.8 million at Celularity, down from -$15.5 million in the prior quarter.
  • Over the last five years, Equity Average for CELU hit a ceiling of $181.6 million in Q4 2022 and a floor of -$630.1 million in Q2 2021.
  • Median Equity Average over the past 5 years was $35.6 million (2023), compared with a mean of -$17.8 million.
  • Biggest five-year swings in Equity Average: surged 156.95% in 2022 and later tumbled 201.11% in 2025.
  • Celularity's Equity Average stood at $97.8 million in 2021, then surged by 85.62% to $181.6 million in 2022, then plummeted by 80.39% to $35.6 million in 2023, then tumbled by 63.32% to $13.1 million in 2024, then crashed by 274.56% to -$22.8 million in 2025.
  • The last three reported values for Equity Average were -$22.8 million (Q3 2025), -$15.5 million (Q2 2025), and $1.7 million (Q1 2025) per Business Quant data.